Ursprung des Netzwerks ersten Grades von Benjamin Hadida
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Exeliom Biosciences
Exeliom Biosciences BiotechnologyHealth Technology Nextbiotix SAS operates as clinical-stage Biopharmaceutical Company, which develops probiotics. The company was founded by Benjamin Hadida, Harry Sokol, Philippe Langella and Patrick Gervais in 2016 and is headquartered in Dijon, France.
5
| Holding Company | Biotechnology | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Benjamin Hadida
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
CELLECTIS S.A. | Pharmaceuticals: Major | Founder | |
Elaia Partners SAS
Elaia Partners SAS Investment ManagersFinance Elaia Partners SAS (Elaia) is an independent French private equity boutique which was founded in 2002. Named after the Greek word for olive tree, the symbol of resilience, longevity and prosperity, Elaia focuses on software technology companies. The firm is headquartered in Paris and manages Elaia Ventures, a French FCPR fund backed by financial institutions, industrial investors and family offices. | Investment Managers | Private Equity Investor | |
Capgemini Consulting SAS
Capgemini Consulting SAS Miscellaneous Commercial ServicesCommercial Services Capgemini Consulting SAS provides management consulting and outsourcing services. The firm advises and supports organizations in transforming their business. The company was founded on July 12, 2004 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Kea & Partners SAS
Kea & Partners SAS Miscellaneous Commercial ServicesCommercial Services Kea & Partners provides consulting services. The company was founded by Hervé Lefèvre, Hervé Baculard, Jérôme Danon, Marc Smia and François Zoetelief Tromp on September 19, 2001 and is headquartered in Malakoff, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
London School of Economics & Political Science | College/University | Graduate Degree | |
École des Hautes Études Commerciales du Nord | College/University | Undergraduate Degree | |
Else Care SAS
Else Care SAS Internet Software/ServicesTechnology Services Else Care SAS operates as an online platform for the sick. It serves as a social media that allows patients to share and communicate information about themselves, their diseases, and its treatments. The firm also aims to let its users find practical help from people with similar health issues, deal better with their sickness on a day-to-day basis, and contribute to the progress of medicine. The company was founded by Michael Chekroun in 2011 and is headquartered in Paris, France. | Internet Software/Services | Chief Executive Officer | |
Mablink Bioscience
Mablink Bioscience Pharmaceuticals: MajorHealth Technology Mablink Bioscience is a biotechnology company based in Lyon, France that develops next-generation antibody-drug conjugates for the treatment of solid tumors. Mablink Bioscience's exclusive PSarlink™ platform is a unique stealth technology that "masks" the hydrophobicity of the cytotoxic drugs by adding a polysarcosine chain to the linker. The French company's pipeline is built on the topoisomerase-I inhibitor exatecan as a payload for current developments. Recently, the company announced the publication of a review article titled “Payload Diversification\: A Key Step in the Development of Antibody–Drug Conjugates” which reviews the history of the successes and failures in ADC payloads and takes a look at the new roads currently explored by the industry. The company was founded in 2018 by Warren Viricel and Jean-Guillaume Lafay, with Jean-Guillaume Lafay serving as CEO since then. | Pharmaceuticals: Major | Chairman | |
Cell-Easy SAS
Cell-Easy SAS Miscellaneous Commercial ServicesCommercial Services Cell-Easy SAS operates as a stem cell contract development and manufacturing organization. It offers ready-to-inject adipose-derived allogeneic stem cells for preclinical and clinical drug development projects. The company is headquartered in Toulouse, France. | Miscellaneous Commercial Services | Director/Board Member | |
Omics SAS | Director/Board Member | ||
Cellectis AB
Cellectis AB BiotechnologyHealth Technology Part of Takara Holdings, Inc., Cellectis AB is a Swedish company that manufactures and distributes stem cell-related products. The company is based in Gothenburg, Sweden. Cellectis was acquired by Takara Bio, Inc. from Cellectis SA on September 04, 2014. | Biotechnology | Director/Board Member | |
EnobraQ SAS
EnobraQ SAS Chemicals: Major DiversifiedProcess Industries EnobraQ SAS develops yeast for the production of chemical compounds. The company was founded on November 13, 2015 and is headquartered in Ramonville-Saint-Agne, France. | Chemicals: Major Diversified | Director/Board Member | |
Département de la Seine-Saint-Denis (France) | Province/State | Director/Board Member | |
Medicen Paris Region
Medicen Paris Region Hospital/Nursing ManagementHealth Services Medicen Paris Region is a health competitiveness cluster based in the Île-de-France region. The French company aims to promote local industrialization and respond to health sovereignty challenges. The non-profit company offers various job opportunities that can be found on their website. | Hospital/Nursing Management | Director/Board Member | |
Eukarys SAS | Director/Board Member | ||
Bilhi Genetics SAS
Bilhi Genetics SAS Pharmaceuticals: OtherHealth Technology Bilhi Genetics SAS specializes in the development of predictive medicines. It offers products for hepatic fibrosis and skin scars. The company was founded by David Sourdive and Pierre Dessein in June 2012 and is headquartered in Marseille, France. | Pharmaceuticals: Other | Founder | |
Mediterranean Institute For Life Sciences | Director/Board Member | ||
Ecole Polytechnique | College/University | Undergraduate Degree | |
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | President | |
Ernst & Young Audit SAS (France)
Ernst & Young Audit SAS (France) Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young Audit SAS (France) is a French company that provides auditing and accounting services. The company is based in Courbevoie, France. Founded in 1987. | Miscellaneous Commercial Services | Corporate Officer/Principal |
Statistik
International
Frankreich | 18 |
Schweden | 3 |
Vereinigtes Königreich | 2 |
Kroatien | 2 |
Sektoral
Health Technology | 6 |
Commercial Services | 6 |
Consumer Services | 4 |
Finance | 2 |
Technology Services | 2 |
Operativ
Director/Board Member | 11 |
Founder | 7 |
Corporate Officer/Principal | 7 |
Chairman | 3 |
Chief Executive Officer | 2 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
David Sourdive | 16 |
Michael Chekroun | 7 |
Harry Sokol | 1 |
Philippe Langella | 1 |
Patrick Gervais | 1 |
- Börse
- Insiders
- Benjamin Hadida
- Unternehmensverbindungen